Inventor · disambiguated record
Cuihua Gao
Also filed as: GAO CUIHUA
9 granted patents·3 pending applications·34 citations·filing 2012–2025
85Inventor score
Top patents by PatentIndex Score
12 records- 0195US10442854B2Neutralizing anti-influenza binding molecules and uses thereofMEDIMMUNE LLC·Filed 2016·Granted Oct 15, 2019·13 cites·11 claims
- 0292US10744204B2Conjugated compounds comprising cysteine-engineered antibodiesMEDIMMUNE LLC·Filed 2015·Granted Aug 18, 2020·8 cites·15 claims
- 0390US11203633B2Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas pervMEDIMMUNE LTD·Filed 2020·Granted Dec 21, 2021·2 cites·25 claims
- 0489US10882897B2Neutralizing anti-influenza binding molecules and uses thereofMEDIMMUNE LLC·Filed 2019·Granted Jan 5, 2021·3 cites·14 claims
- 0584US10160812B2Bispecific HER2 antibodiesMEDIMMUNE LLC·Filed 2015·Granted Dec 25, 2018·4 cites·18 claims
- 0682US11926657B2Neutralizing anti-influenza binding molecules and uses thereofMEDIMMUNE LLC·Filed 2022·Granted Mar 12, 2024·0 cites·13 claims
- 0781US10597439B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LLC·Filed 2012·Granted Mar 24, 2020·4 cites·7 claims
- 0877US12428473B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LTD·Filed 2021·Granted Sep 30, 2025·0 cites·20 claims
- 0972US2025243262A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LTD·Filed 2025·Application pending·0 cites
- 1071US11524993B2Neutralizing anti-influenza binding molecules and uses thereofMEDIMMUNE LLC·Filed 2020·Granted Dec 13, 2022·0 cites·14 claims
- 1160US2021069341A1Conjugated compounds comprising cysteine-engineered antibodiesMEDIMMUNE LLC·Filed 2020·Application pending·0 cites
- 1236US2017183397A1Multi-specific anti-pseudomonas psl and pcrv binding molecules and uses thereofMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cuihua Gao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →